Annual ROE
-29.44%
-46.87%-268.90%
December 31, 2023
Summary
- As of February 8, 2025, CRVO annual return on equity is -29.44%, with the most recent change of -46.87% (-268.90%) on December 31, 2023.
- During the last 3 years, CRVO annual ROE has risen by +27.73% (+48.50%).
- CRVO annual ROE is now -100.18% below its all-time high of 16.15 thousand%, reached on December 1, 2015.
Performance
CRVO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-44.11%
-16.19%-57.99%
September 30, 2024
Summary
- As of February 8, 2025, CRVO quarterly return on equity is -44.11%, with the most recent change of -16.19% (-57.99%) on September 30, 2024.
- Over the past year, CRVO quarterly ROE has increased by +1.37% (+3.01%).
- CRVO quarterly ROE is now -101.44% below its all-time high of 3061.39%, reached on December 1, 2011.
Performance
CRVO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CRVO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -268.9% | +3.0% |
| 3 y3 years | +48.5% | +3.0% |
| 5 y5 years | +75.0% | +3.0% |
CRVO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -268.9% | +57.4% | -141.0% | +52.4% |
| 5 y | 5-year | -268.9% | +57.4% | -141.0% | +52.4% |
| alltime | all time | -100.2% | +99.1% | -101.4% | +99.2% |
CervoMed ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -44.11%(+58.0%) |
| Jun 2024 | - | -27.92%(-38.6%) |
| Mar 2024 | - | -45.48%(+148.5%) |
| Dec 2023 | -29.44%(-268.9%) | -18.30%(-76.7%) |
| Sep 2023 | - | -78.66%(-4.3%) |
| Jun 2023 | - | -82.16%(-2.9%) |
| Mar 2023 | - | -84.65%(-8.6%) |
| Dec 2022 | 17.43%(-125.3%) | - |
| Dec 2022 | - | -92.62%(+105.9%) |
| Sep 2022 | - | -44.99%(-39.9%) |
| Jun 2022 | - | -74.86%(+20.1%) |
| Mar 2022 | - | -62.35%(+14.4%) |
| Dec 2021 | -69.02%(+20.7%) | -54.50%(-8.0%) |
| Sep 2021 | - | -59.21%(+37.6%) |
| Jun 2021 | - | -43.02%(-7.4%) |
| Mar 2021 | - | -46.47%(-14.6%) |
| Dec 2020 | -57.17%(-2.4%) | -54.39%(-2.4%) |
| Sep 2020 | - | -55.70%(-3.9%) |
| Jun 2020 | - | -57.99%(-15.4%) |
| Mar 2020 | - | -68.57%(-8.8%) |
| Dec 2019 | -58.60%(-50.2%) | -75.17%(-19.6%) |
| Sep 2019 | - | -93.49%(-12.5%) |
| Jun 2019 | - | -106.83%(+15.2%) |
| Mar 2019 | - | -92.76%(+18.1%) |
| Dec 2018 | -117.67%(+1730.0%) | -78.55%(+76.9%) |
| Sep 2018 | - | -44.41%(-1262.6%) |
| Jun 2018 | - | 3.82%(-97.7%) |
| Mar 2018 | - | 163.90%(-389.4%) |
| Dec 2017 | -6.43%(-96.7%) | -56.64%(-106.0%) |
| Sep 2017 | - | 950.43%(-139.8%) |
| Jun 2017 | - | -2390.77%(+130.3%) |
| Mar 2017 | - | -1038.24%(+638.0%) |
| Dec 2016 | -196.38%(-101.2%) | -140.69%(-18.7%) |
| Sep 2016 | - | -172.99%(+51.5%) |
| Jun 2016 | - | -114.22%(+64.6%) |
| Mar 2016 | - | -69.41%(+122.3%) |
| Dec 2015 | 16.15 K% | -31.22%(+7.0%) |
| Sep 2015 | - | -29.17%(-2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | -29.97%(-14.9%) |
| Mar 2015 | - | -35.21%(-15.1%) |
| Dec 2014 | -37.61%(-7.8%) | -41.46%(+7.8%) |
| Sep 2014 | - | -38.46%(-33.5%) |
| Jun 2014 | - | -57.85%(-63.9%) |
| Mar 2014 | - | -160.28%(-527.0%) |
| Dec 2013 | -40.81%(-209.2%) | 37.54%(-134.8%) |
| Sep 2013 | - | -107.83%(-1.9%) |
| Jun 2013 | - | -109.90%(-249.7%) |
| Mar 2013 | - | 73.40%(-15.2%) |
| Dec 2012 | 37.36%(-73.5%) | 86.53%(-83.0%) |
| Sep 2012 | - | 508.37%(-42.5%) |
| Jun 2012 | - | 884.35%(-54.4%) |
| Mar 2012 | - | 1940.80%(-36.6%) |
| Dec 2011 | 141.19%(-104.3%) | 3061.39%(-901.3%) |
| Sep 2011 | - | -382.03%(-1.7%) |
| Jun 2011 | - | -388.68%(-63.6%) |
| Mar 2011 | - | -1069.14%(+30.7%) |
| Dec 2010 | -3273.38%(+348.8%) | -818.19%(+19.1%) |
| Sep 2010 | - | -686.73%(-4.9%) |
| Jun 2010 | - | -722.12%(-18.1%) |
| Mar 2010 | - | -881.52%(-10.3%) |
| Dec 2009 | -729.39%(+53.0%) | -982.58%(-82.4%) |
| Sep 2009 | - | -5595.32%(+17.9%) |
| Jun 2009 | - | -4744.49%(-555.1%) |
| Mar 2009 | - | 1042.55%(+114.0%) |
| Dec 2008 | -476.83%(-7206.3%) | 487.07%(-663.5%) |
| Sep 2008 | - | -86.44%(+4.2%) |
| Jun 2008 | - | -82.96%(-9.3%) |
| Mar 2008 | - | -91.43%(-643.9%) |
| Dec 2007 | 6.71%(-80.1%) | 16.81%(-97.7%) |
| Sep 2007 | - | 726.11%(+45.6%) |
| Jun 2007 | - | 498.59%(+50.3%) |
| Mar 2007 | - | 331.66%(+422.3%) |
| Dec 2006 | 33.64%(-574.5%) | 63.50% |
| Dec 2005 | -7.09%(-96.4%) | - |
| Dec 1999 | -194.91%(-5454.7%) | - |
| Dec 1998 | 3.64% | - |
FAQ
- What is CervoMed annual return on equity?
- What is the all time high annual ROE for CervoMed?
- What is CervoMed annual ROE year-on-year change?
- What is CervoMed quarterly return on equity?
- What is the all time high quarterly ROE for CervoMed?
- What is CervoMed quarterly ROE year-on-year change?
What is CervoMed annual return on equity?
The current annual ROE of CRVO is -29.44%
What is the all time high annual ROE for CervoMed?
CervoMed all-time high annual return on equity is 16.15 K%
What is CervoMed annual ROE year-on-year change?
Over the past year, CRVO annual return on equity has changed by -46.87% (-268.90%)
What is CervoMed quarterly return on equity?
The current quarterly ROE of CRVO is -44.11%
What is the all time high quarterly ROE for CervoMed?
CervoMed all-time high quarterly return on equity is 3061.39%
What is CervoMed quarterly ROE year-on-year change?
Over the past year, CRVO quarterly return on equity has changed by +1.37% (+3.01%)